BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9149288)

  • 1. An amphipathic alpha-helical synthetic peptide analogue of melittin inhibits herpes simplex virus-1 (HSV-1)-induced cell fusion and virus spread.
    Baghian A; Jaynes J; Enright F; Kousoulas KG
    Peptides; 1997; 18(2):177-83. PubMed ID: 9149288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell fusion caused by herpes simplex virus-1 (HSV-1) strains tsB5 and MP is inhibited at pH 6.7 and pH 7.0.
    Baghian A; Dietrich MA; Kousoulas KG
    Arch Virol; 1992; 122(1-2):119-31. PubMed ID: 1309636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Na+,K+ pump in herpes simplex type 1-induced cell fusion: melittin causes specific reversion of syncytial mutants with the syn1 mutation to Syn+ (wild-type) phenotype.
    Baghian A; Kousoulas KG
    Virology; 1993 Oct; 196(2):548-56. PubMed ID: 8396802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in glycoprotein gB specified by mutants and their partial revertants in herpes simplex virus type 1 and relationship to other mutant phenotypes.
    Haffey ML; Spear PG
    J Virol; 1980 Jul; 35(1):114-28. PubMed ID: 6251260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type 1 glycoprotein K is not essential for infectious virus production in actively replicating cells but is required for efficient envelopment and translocation of infectious virions from the cytoplasm to the extracellular space.
    Jayachandra S; Baghian A; Kousoulas KG
    J Virol; 1997 Jul; 71(7):5012-24. PubMed ID: 9188566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
    Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
    Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UL21 Tegument Protein of Herpes Simplex Virus 1 Is Differentially Required for the Syncytial Phenotype.
    Sarfo A; Starkey J; Mellinger E; Zhang D; Chadha P; Carmichael J; Wills JW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus glycoprotein K, but not its syncytial allele, inhibits cell-cell fusion mediated by the four fusogenic glycoproteins, gD, gB, gH, and gL.
    Avitabile E; Lombardi G; Campadelli-Fiume G
    J Virol; 2003 Jun; 77(12):6836-44. PubMed ID: 12768003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single amino acid substitutions in the glycoprotein B carboxy terminus influence the fusion from without property of herpes simplex virus type 1.
    Lingen M; Seck T; Weise K; Falke D
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1843-9. PubMed ID: 9049391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
    Härle P; Sainz B; Carr DJ; Halford WP
    Virology; 2002 Feb; 293(2):295-304. PubMed ID: 11886249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules.
    Galdiero S; Vitiello M; D'Isanto M; Falanga A; Cantisani M; Browne H; Pedone C; Galdiero M
    Chembiochem; 2008 Mar; 9(5):758-67. PubMed ID: 18311743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs.
    Srinivas RV; Birkedal B; Owens RJ; Anantharamaiah GM; Segrest JP; Compans RW
    Virology; 1990 May; 176(1):48-57. PubMed ID: 2158697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
    Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
    Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
    Pertel PE; Spear PG
    Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96.
    Schwartz JA; Lium EK; Silverstein SJ
    J Virol; 2001 May; 75(9):4117-28. PubMed ID: 11287561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A inhibits herpes simplex virus-induced cell fusion but not virus penetration into cells.
    McKenzie RC; Epand RM; Johnson DC
    Virology; 1987 Jul; 159(1):1-9. PubMed ID: 3037772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.
    Albiol Matanic VC; Castilla V
    Int J Antimicrob Agents; 2004 Apr; 23(4):382-9. PubMed ID: 15081088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells.
    Delboy MG; Patterson JL; Hollander AM; Nicola AV
    Virol J; 2006 Dec; 3():105. PubMed ID: 17192179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus (HSV) glycoproteins B and K inhibit cell fusion induced by HSV syncytial mutants.
    Hutchinson L; Graham FL; Cai W; Debroy C; Person S; Johnson DC
    Virology; 1993 Oct; 196(2):514-31. PubMed ID: 8396800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteines and N-Glycosylation Sites Conserved among All Alphaherpesviruses Regulate Membrane Fusion in Herpes Simplex Virus 1 Infection.
    Rider PJF; Naderi M; Bergeron S; Chouljenko VN; Brylinski M; Kousoulas KG
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.